The Brightline Initiative Announces the Addition of Saudi Telecom Company - STC
The Brightline Initiative announced today that Saudi Telecom Company (STC) is joining the Brightline Initiative coalition to help advance the discipline of strategic initiative management and bridge gaps between enterprise strategy design and delivery.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171121005474/en/
Signature of Coalition agreement by STC Group CEO, Dr. Khaled Biyari and Brightline Executive Director Ricardo Vargas (Photo: Business Wire)
The initiative’s agreement has been signed by STC Group CEO, Dr. Khaled Biyari and by Brightline Executive Director Ricardo Vargas.
Launched early in 2017 by the Project Management Institute (PMI), the Boston Consulting Group (BCG) and the Agile Alliance, the Brightline Initiative is a non-commercial coalition dedicated to helping executives bridge the expensive and unproductive gap between strategy design and delivery.
“STC has a profound expertise and a renowned success in building and executing strategies. We are looking forward to joining a coalition that brings together leading organizations and academics worldwide to address the critical business issue of successful strategy delivery,” says STC Group CEO, Dr. Khaled Biyari. He added: “For STC, this capability is core to capturing emerging opportunities in the MENA while remaining a leader in ICT and managing overall challenges over the coming years.”
A report from a global multi-sector survey of 500 senior executives conducted by The Economist Intelligence Unit (EIU) and commissioned by the Brightline Initiative found that nearly 90% of global survey respondents admit they fail to achieve all their strategic goals because they don’t implement well, and more than half (53 percent) agree that inadequate delivery capability puts them at a competitive disadvantage.
Brightline executive director Ricardo Vargas says, “The Brightline Initiative welcomes STC to our growing ranks as we help organizations bridge the strategy implementation gap in an era of disruption and social and economic challenges. It is important to highlight that strategies are just passive plans on a piece of paper unless organizations find ways to impact employee behaviors and instill new ways of working together.”
About The Brightline Initiative
The Brightline Initiative is a coalition of leading global organizations dedicated to helping executives bridge the expensive and unproductive gap between strategy design and strategy delivery. Brightline conducts thought leadership research and promotes best practices designed to improve an organization’s ability to deliver on strategic intent.
With their headquarters in Riyadh, Saudi Telecom Group is the largest in the Middle East and North Africa based on its market value as it generated over 51,825 billion riyals (13,825 billion dollars) in realizable revenue in 2016 and 8,539 billion riyals (2,277 billion dollars) as net income. STC was established in 1998 and currently counts about 100,000,000 customers worldwide and to which they provide high-technology knowledge-based innovative solutions. It focuses on providing services to customers through a fiber-optic network that spans 137,000 kilometers across Asia, the Middle East and Europe. In Saudi Arabia (the group’s main operation site) STC operates the largest modern mobile network in the Middle East as it covers more than 99% of the country’s populated areas in addition to providing 4G mobile broadband to more than 85% of the population across the Kingdom of Saudi Arabia. Besides its main operation in Saudi Arabia, which it owns 100% of, STC’s investments include 100% ownership in Viva Bahrain, 51.8% shares in Viva Kuwait along with a management contract, 35% shares in Oger Telecom Limited in UAE and which controls Turk Telecom, Avea in Turkey, Cell-C in South Africa, 25% shares in Binariang GSM Holding in Malaysia which controls both Maxis in Malaysia and Aircel in India. In addition to the above-mentioned, STC has investments in information technology, content, distribution, contact centers and real estate, all of which support its telecom operations across the Middle East.
1] Economist Intelligence Unit (EIU), “Closing the Gap: Designing and Delivering a Strategy that Works”, 2017.
Tahirou Assane, +1 613-981-8211
Director of Operations and Program
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
European Commission approves Ipsen’s Cabometyx® (cabozantinib) for the treatment of hepatocellular carcinoma in adults previously treated with sorafenib15.11.2018 09:30 | Tiedote
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the European Commission (EC) has approved Cabometyx® (cabozantinib) 20, 40, 60 mg as a monotherapy for hepatocellular carcinoma (HCC) in adults who have previously been treated with sorafenib. This approval allows for the marketing of Cabometyx® (cabozantinib) in this indication in all 28 member states of the European Union, Norway and Iceland. “Today’s EC approval for the use of Cabometyx ® provides a much needed new option for HCC patients. Until now, physicians in Europe had only one approved therapy for the 2 nd line treatment of this aggressive and difficult-to-treat cancer.1,2 We are proud to offer Cabometyx ® as an innovative treatment that has been shown to extend survival in previously treated patients with HCC,” said Harout Semerjian, Chief Commercial Officer, Ipsen. “This new indication reinforces Ipsen’s commitment to improve patients’ lives through the expansion of the clinical benefit of Cabometyx ® i
Mobidiag nostaa viimeisen €4M erän Euroopan investointipankin €15M rahoituksesta15.11.2018 09:30 | Tiedote
Mobidiag Oy, vahvassa kasvuvaiheessa oleva molekyylidiagnostiikkayhtiö, joka taistelee antibioottiresistenssin leviämistä vastaan, ilmoitti tänään, että se on nostanut viimeisen 4 miljoonan euron erän 15 miljoonan euron lainasta, jonka Euroopan investointipankki (EIP) myönsi yhtiölle kolmivuotiseen projektiin heinäkuussa 2016. Laina myönnettiin osana EIP:n ”InnovFin - EU Finance for innovators” -ohjelmaa. Ohjelman tavoitteena on tukea innovatiivisten eurooppalaisten yhtiöiden haastavia korkean teknologian kehityshankkeita mahdollistamalla rahoituksen. Tämä lehdistötiedote sisältää multimediaa. Katso koko julkaisu täällä: https://www.businesswire.com/news/home/20181114005789/fi/ Aiemmin nostettujen EIP:n lainaerien avulla Mobidiag on kehittänyt valmiiksi ja kaupallistanut Novodiag® -molekyylidiagnostiikan järjestelmänsä sekä kaksi suolistoinfektioiden aiheuttajien tunnistamiseen käytettävää testiä (Novodiag® C. difficile ja Novodiag® Bacterial GE+). Viimeisen lainaerän avulla yhtiö nope
Mobidiag Receives Final €4M Tranche of €15M EIB Financing15.11.2018 09:30 | Tiedote
Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, announced today that it has received the final €4M tranche of a €15M three-year project secured by the Company from the European Investment Bank Group (EIB) in July 2016. The loan was provided as part of “InnovFin – EU Finance for innovators” programme, an EIB initiative aimed at providing innovative and high quality companies in Europe with access to finance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181114005786/en/ The EIB funding has already enabled Mobidiag to finalize, launch and commercialize its Novodiag® molecular diagnostic system and two assays for detection of gastrointestinal infections (Novodiag® C. difficile and Novodiag® Bacterial GE+). The final tranche will enable the Company to continue growing its product portfolio, accelerate the development of further assays for the Novodiag® system an
Highlights of China’s No. 1 High-Tech Fair CHTF 201815.11.2018 05:00 | Tiedote
The 20th China Hi-Tech Fair (CHTF 2018) is being held from November 14-18 at the Shenzhen Convention and Exhibition Center with the theme “New Development Concept for High Quality Growth.” This year’s CHTF consists of exhibitions, forums, professional meetings, supporting activities, talents exchange meetings and overseas fairs, and features advanced manufacturing, next-generation information technology, AI, life sciences, new materials, new energy, as well as integration of real economy and future industries. Here are some of the highlights of CHTF 2018: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181114005654/en/ International and Belt & Road Pavilion of CHTF (Photo: Business Wire) Themed areas focusing on industry hotspots The IT exhibition will present themed areas like AI, smart manufacturing, smart automotive, sports technology, big data, cloud computing, IoT and blockchain; the environmental exhibition will highlig
MapleStory Prepares for Epic Battle Against the Black Mage in Gathering of Heroes Event15.11.2018 00:00 | Tiedote
MapleStory, the iconic global MMORPG from Nexon America, is bringing the first phase of its long-awaited battle with the sinister villain, the Black Mage. Between November 14 through November 28, players can take part in the “Gathering of Heroes” event to join the Maple Alliance and prepare their armies to soon combat the Black Mage. The Black Mage has long been the main antagonist behind MapleStory. His story originated with the role of bringing balance to Maple World, but turned dark as he realized the only way to save Maple World was to destroy it. Now that his seal has been broken, players will need to work together to defeat the legendary boss. The Gathering of Heroes event adds the Maple Alliance outpost, where players can hone their skills and prepare to level up in preparation of for their battle against the Black Mage, as well as adds various leveling updates. The main goal of the Alliance is to gather “Determination” and power up the holy light in the outpost to be able to fi
SpinalCyte Announces Sustained 12-Month MRI Outcomes After CybroCell™ Injection14.11.2018 23:07 | Tiedote
SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using its universal donor product, CybroCell™, today announced that a single injection of modified human dermal fibroblasts (HDFs), resulted in significant improvements of disc height and pain reduction 12 months after injection of the cell therapy for patients with degenerative disc disease (DDD). The trial assessed patients using the Oswestry Disability Index (ODI), Visual Analogue Scale (VAS) and disc height via MRI scans. Using composite scoring, 54% of the treatment arm patients met all three endpoints as compared to only 17% with the placebo (p=0.0003). Over 84% of patients in the treatment group of CybroCell™ or CybroCell™ with platelet rich plasma (PRP) injections had an increase or no change in disc height compared to 25% for the placebo saline injection. Analyzed individually, 83% of spinal discs that were injected with CybroCell™ had an increase or no change in disc he
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme